InvestorsHub Logo
Followers 0
Posts 46
Boards Moderated 0
Alias Born 04/19/2004

Re: DewDiligence post# 142

Tuesday, 04/27/2004 8:23:30 AM

Tuesday, April 27, 2004 8:23:30 AM

Post# of 9289
Mapping with riggs -what has been said

Point 1.You must find something that you wouldn’t have found without mapping

-Occult tumor was confirmed in 21% of the recurrent patients and 14% of primary patients

Point 2 Finding whatever you found that you wouldn’t have found otherwise has to make a difference to the patient’s outcome.

survival data from RIGS clinical trials in both recurrent and primary colorectal studies emerged from clinical investigators that confirmed the prognostic nature of RIGS-positive tissue

This BLA stage product seems like a good bet for seventy cents
a share


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NAVB News